These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 6619074)

  • 21. [Primaquine sensitivity of sheep erythrocytes].
    Singh MK; Vincke E
    Arzneimittelforschung; 1965 Aug; 15(8):917-9. PubMed ID: 5898648
    [No Abstract]   [Full Text] [Related]  

  • 22. [Attempt at preventing the hemolytic action of primaquine in persons with a gluose-6-phosphate dehydrogenase activity deficit in the erythrocytes by the simultaneous administration of xylitol and riboflavin].
    Idel'son LI; Rustamov RSh; Lysenko AIa; Abrashkin-Zhuchkov RG; Gorbunova IuP
    Probl Gematol Pereliv Krovi; 1973 Mar; 18(3):24-8. PubMed ID: 4272104
    [No Abstract]   [Full Text] [Related]  

  • 23. Drug-induced haemolysis in glucose-6-phosphate dehydrogenase deficiency.
    Chan TK; Todd D; Tso SC
    Br Med J; 1976 Nov; 2(6046):1227-9. PubMed ID: 990860
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sickle cell hemoglobin, primaquine sensitivity and their correlation. 1. Sickle cell hemoglobin.
    Lewis RA
    J Postgrad Med; 1966 Jan; 12(1):1-12. PubMed ID: 5908159
    [No Abstract]   [Full Text] [Related]  

  • 25. Glucose 6-phosphate dehydrogenase deficiency: from genotype to phenotype.
    Luzzatto L
    Haematologica; 2006 Oct; 91(10):1303-6. PubMed ID: 17018377
    [No Abstract]   [Full Text] [Related]  

  • 26. Primaquine, malaria chemotherapy and G-6-PD deficiency.
    Goldsmid JM; Jupe D; Melrose W
    Med J Aust; 1984 Sep; 141(5):310-1. PubMed ID: 6472168
    [No Abstract]   [Full Text] [Related]  

  • 27. Studies of in vitro primaquine hemolysis: substrate requirement for erythrocyte membrane damage.
    George JN; O'Brien RL; Pollack S; Crosby WH
    J Clin Invest; 1966 Aug; 45(8):1280-9. PubMed ID: 5926074
    [No Abstract]   [Full Text] [Related]  

  • 28. Glucose-6-phosphate dehydrogenase deficiency and the use of primaquine: top-down and bottom-up estimation of professional costs.
    Peixoto HM; Brito MAM; Romero GAS; Monteiro WM; Lacerda MVG; Oliveira MRF
    Rev Saude Publica; 2017 Oct; 51():90. PubMed ID: 29020124
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical pharmacology of diformyldapsone.
    Cucinell SA; Rebert C; Clyde D
    J Clin Pharmacol; 1974 Jan; 14(1):51-7. PubMed ID: 4491908
    [No Abstract]   [Full Text] [Related]  

  • 30. The hemolytic effect of primaquine V. Primaquine sensitivity as a manifestation of a multiple drug sensitivity.
    Dern RJ; Beutler E; Alving AS
    J Lab Clin Med; 1981 Jun; 97(6):750-9. PubMed ID: 7229509
    [No Abstract]   [Full Text] [Related]  

  • 31. Glucose-6-phosphate dehydrogenase deficiency and antimalarial drug development.
    Beutler E; Duparc S;
    Am J Trop Med Hyg; 2007 Oct; 77(4):779-89. PubMed ID: 17978087
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Primaquine and travelers from the Arab world. A report and recommendations].
    Menéndez Capote R; Caña Lugo C; Fernández Núñez A
    Rev Cubana Med Trop; 1995; 47(3):221-3. PubMed ID: 9813483
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Pharmacogenetics].
    Lamy M
    Nouv Presse Med; 1972 Dec; 1(46):3103-6. PubMed ID: 4650508
    [No Abstract]   [Full Text] [Related]  

  • 34. Danger of haemolysis from primaquine use.
    Reilly Q
    P N G Med J; 1982 Sep; 25(3):194. PubMed ID: 6961647
    [No Abstract]   [Full Text] [Related]  

  • 35. [Neonatal jaundice with intra-erythrocyte G-6-PD deficiency].
    Baldini MG; D'Onofrio A; Forte A; Meiattini MT; Ungaro P
    Minerva Pediatr; 1980 Apr; 32(8):563-70. PubMed ID: 7393189
    [No Abstract]   [Full Text] [Related]  

  • 36. [Hemolytic effect of primaquine and the protective properties of sodium formate in vitro].
    Grinberg LN; Allakhverdiev AM
    Med Parazitol (Mosk); 1981; 50(2):54-7. PubMed ID: 7231374
    [No Abstract]   [Full Text] [Related]  

  • 37. [New use of primaquine for malaria].
    Oliver M; Simon F; de Monbrison F; Beavogui AH; Pradines B; Ragot C; Moalic JL; Rapp C; Picot S
    Med Mal Infect; 2008 Apr; 38(4):169-79. PubMed ID: 18395381
    [TBL] [Abstract][Full Text] [Related]  

  • 38. G 6 PD deficiency induced hemolysis in diabetic twins.
    Haroun M
    Indian Pediatr; 2005 Jul; 42(7):705-7. PubMed ID: 16085973
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sites of destruction of red cells in G-6-PD deficient Caucasians and in phenylhydrazine treated patients.
    Tizianello A; Pannacciulli I; Ajmar F; Salvidio E
    Scand J Haematol; 1968; 5(2):116-28. PubMed ID: 5673824
    [No Abstract]   [Full Text] [Related]  

  • 40. [Recurrence problems with preventive primaquine treatment in patients with malaria].
    Rønn AM; Bygbjerg IC
    Ugeskr Laeger; 1993 Nov; 155(48):3901-4. PubMed ID: 8273193
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.